Priser
Platform
Blog
Om os
Download
Jilin Province Huinan Changlong Bio-pharmacy Co
Jilin Province Huinan Changlong Bio-pharmacy Co
Hong Kong Stock Exchange
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY CO MED ENDAVU: Køb Jilin Province Huinan Changlong Bio-pharmacy Co ($8049) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jilin Province Huinan Changlong Bio-pharmacy Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.

Information

TickerLADR
Land
USA
CEOMr. Brian Harris
Antal medarbejdere60
Hjemmesideladdercapital.com
SektorEjendomme
IndustriREIT - Lån

Udbytter

0,8USD
'21
0,88USD
'22
0,92USD
'23
0,92USD
'24
0,92USD
'25
0,46USD
'26
Ex-udbytte-dato30. jun. 2026
Udbytteafkast8,86%

Analytikerskøn

Baseret på 7 analytikere

Stærkt købKøbHoldSælgStærkt sælg
29%57%14%0%0%